The VAD Scheme versus Thalidomide plus VAD for Reduction of Vascular Endothelial Growth Factor in Multiple Myeloma: A Meta-Analysis

Figure 4

Forest plot comparing overall efficacy of the T-VAD regimen to the VAD regimen for MM treatment.